These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18633453)

  • 1. On Using Truncated Sequential Probability Ratio Test Boundaries for Monte Carlo Implementation of Hypothesis Tests.
    Fay MP; Kim HJ; Hachey M
    J Comput Graph Stat; 2007; 16(4):946-967. PubMed ID: 18633453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bounding the Resampling Risk for Sequential Monte Carlo Implementation of Hypothesis Tests.
    Kim HJ
    J Stat Plan Inference; 2010 Jul; 140(7):1834-1843. PubMed ID: 20514142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of futility boundaries for group sequential designs with two endpoints.
    Schüler S; Kieser M; Rauch G
    BMC Med Res Methodol; 2017 Aug; 17(1):119. PubMed ID: 28789615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
    Sebille V; Bellissant E
    Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiway contingency tables: Monte Carlo resampling probability values for the chi-squared and likelihood-ratio tests.
    Long MA; Berry KJ; Mielke PW
    Psychol Rep; 2010 Oct; 107(2):501-10. PubMed ID: 21117477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint.
    Li X; Herrmann C; Rauch G
    BMC Med Res Methodol; 2020 Nov; 20(1):274. PubMed ID: 33153438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the efficiency of the independent segments procedure: A direct comparison with sequential probability ratio tests.
    Erdfelder E; Schnuerch M
    Psychol Methods; 2021 Aug; 26(4):501-506. PubMed ID: 34726467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early stopping to accept H(o) based on conditional power: approximations and comparisons.
    Betensky RA
    Biometrics; 1997 Sep; 53(3):794-806. PubMed ID: 9290216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using transcription-based detectors to emulate the behavior of sequential probability ratio-based concentration detectors.
    Chou CT
    Phys Rev E; 2022 Nov; 106(5-1):054403. PubMed ID: 36559424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Monte Carlo evaluation of resampling-based hypothesis tests with applications to genetic epidemiology.
    Fung WK; Yu K; Yang Y; Zhou JY
    Stat Methods Med Res; 2018 May; 27(5):1437-1450. PubMed ID: 27507290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conditional maximized sequential probability ratio test for pharmacovigilance.
    Li L; Kulldorff M
    Stat Med; 2010 Jan; 29(2):284-95. PubMed ID: 19941282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Monte Carlo transport and fluence optimization with fluence adjusting scalable transport Monte Carlo.
    Yang YM; Svatos M; Zankowski C; Bednarz B
    Med Phys; 2016 Jun; 43(6):3034-3048. PubMed ID: 27277051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse Events.
    Kashiwabara K; Matsuyama Y; Ohashi Y
    Ther Innov Regul Sci; 2014 Jul; 48(4):444-452. PubMed ID: 30235573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling decision errors with minimal costs: The sequential probability ratio t test.
    Schnuerch M; Erdfelder E
    Psychol Methods; 2020 Apr; 25(2):206-226. PubMed ID: 31497982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
    Tan M; Xiong X
    Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential clinical trials for normal variates using interval composite hypotheses.
    Lachin JM
    Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing nested experimental designs-A user-friendly resampling method to determine experimental significance.
    Kulkarni RU; Wang CL; Bertozzi CR
    PLoS Comput Biol; 2022 May; 18(5):e1010061. PubMed ID: 35500032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of methods for futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.